A61P 9/12
Antihypertensives
A61P9/12 (Antihypertensives) appears on 13,592 US grants and 17,350 published applications in this corpus.
Search patents in A61P- Granted patents
- 13,592
- Published applications
- 17,350
- Assignees
- 4,414
- Inventors
- 28,983
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 32 | 0 |
| 1977 | 41 | 0 |
| 1978 | 64 | 0 |
| 1979 | 66 | 0 |
| 1980 | 59 | 0 |
| 1981 | 88 | 0 |
| 1982 | 85 | 0 |
| 1983 | 65 | 0 |
| 1984 | 95 | 0 |
| 1985 | 132 | 0 |
| 1986 | 125 | 0 |
| 1987 | 164 | 0 |
| 1988 | 132 | 0 |
| 1989 | 154 | 0 |
| 1990 | 118 | 0 |
| 1991 | 146 | 0 |
| 1992 | 138 | 0 |
| 1993 | 129 | 0 |
| 1994 | 148 | 0 |
| 1995 | 197 | 0 |
| 1996 | 162 | 0 |
| 1997 | 175 | 0 |
| 1998 | 156 | 0 |
| 1999 | 161 | 0 |
| 2000 | 182 | 0 |
| 2001 | 222 | 59 |
| 2002 | 261 | 352 |
| 2003 | 236 | 561 |
| 2004 | 230 | 806 |
| 2005 | 269 | 783 |
| 2006 | 309 | 766 |
| 2007 | 321 | 905 |
| 2008 | 351 | 1016 |
| 2009 | 375 | 1227 |
| 2010 | 622 | 1490 |
| 2011 | 652 | 1247 |
| 2012 | 777 | 1136 |
| 2013 | 886 | 869 |
| 2014 | 846 | 828 |
| 2015 | 721 | 780 |
| 2016 | 559 | 719 |
| 2017 | 595 | 645 |
| 2018 | 472 | 550 |
| 2019 | 391 | 544 |
| 2020 | 388 | 467 |
| 2021 | 312 | 370 |
| 2022 | 213 | 320 |
| 2023 | 180 | 273 |
| 2024 | 157 | 274 |
| 2025 | 148 | 220 |
| 2026 | 85 | 143 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Mono- and bis-nitrosylated propanediols for therapeutic use29 Sep 2026US 12,746,215 B2Attgeno Bio
- Treatment for interstitial lung disease22 Sep 2026US 12,740,954 B2United Therapeutics Corporation
- Treatment for interstitial lung disease15 Sep 2026US 12,734,143 B2United Therapeutics Corporation
- Compositions including multi-agonist peptides and methods of manufacture and use15 Sep 2026US 12,735,457 B2Pep2Tango Therapeutics Inc.
- Multi-transgenic pig for Xenotransplantation25 Aug 2026US 12,714,077 B2Revivicor, Inc.
- Treprostinil prodrugs8 Oct 2026US 2026/0306438 A1United Therapeutics Corporation
- Composition for removing and inhibiting senescent cells, and uses thereof8 Oct 2026US 2026/0306460 A1Lifeceutix Co., Ltd.
- Activin receptor type iib variants and uses thereof8 Oct 2026US 2026/0308229 A135PHARMA Inc.
- Prophylactic/therapeutic agent for pregnancy-induced hypertension8 Oct 2026US 2026/0308559 A1Medical Corporation Saneikai
- Methods of Lowering Blood Pressure Using Fixed Doses of MANP1 Oct 2026US 2026/0295012 A1E-Star Biotech, LLC
Most cited
By later US patents
- Solid carriers for improved delivery of active ingredients in pharmaceutical compositions930US 6,248,363 B1Lipocine Inc. · 2001
- Solid carriers for improved delivery of active ingredients in pharmaceutical compositions684US 6,923,988 B2Lipocine Inc. · 2005
- Solid carriers for improved delivery of hydrophobic active ingredients in pharmaceutical compositions616US 6,569,463 B2Lipocine Inc. · 2003
- Hybrid oligonucleotide phosphorothioates427US 5,652,355 AWorcester Foundation for Experimental Biology · 1997
- Aminoacid derivatives as antihypertensives354US 4,374,829 AMerck & Co., Inc. · 1983